Table 2.
TZD use in the Health ABC cohort over four years
| BL-Year 4 (4 yrs) | BL-Yr 2 (1st 2 yrs) | Yr 2-Yr 4 (2nd 2 yrs) | |
|---|---|---|---|
| Number reporting useb | |||
| Any TZD | 69 | 32 | 64 |
| Troglitazone | 22 | 22 | 13 |
| Pioglitazone | 30 | 5 | 30 |
| Rosiglitazone | 31 | 7 | 31 |
| Mean use a (yrs) | |||
| Any TZD | 1.67±1.03 | 1.09±0.60 | 1.25±0.44 |
Mean ± standard
Numbers reporting use of the three specific TZDs do not total to those using “any TZD” since a participant may have used more than one type of TZD during the follow-up period.